Very low‐dose versus standard dose radiation therapy for indolent primary cutaneous B‐cell lymphomas: A retrospective study
暂无分享,去创建一个
A. Ng | S. Isom | K. Winkfield | A. Goyal | S. Gallotto | J. Carter | I. Pashtan | I. Wang
[1] R. Weterings,et al. Geographic Distribution of Otolaryngologists in the United States , 2016, Ear, nose, & throat journal.
[2] Christine F. Wogan,et al. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy , 2016, Leukemia & lymphoma.
[3] A. Dal Cin,et al. Primary Cutaneous B-Cell Lymphoma: Role of Surgery , 2011, The Canadian journal of plastic surgery = Journal canadien de chirurgie plastique.
[4] S. Parker,et al. Intralesional corticosteroid therapy for primary cutaneous B‐cell lymphoma , 2010, The British journal of dermatology.
[5] D. Rigel,et al. Trends in dermatology: geographic density of US dermatologists. , 2010, Archives of dermatology.
[6] E. Noordijk,et al. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas. , 2009, International journal of radiation oncology, biology, physics.
[7] L. Medeiros,et al. Primary cutaneous marginal zone B-cell lymphoma. , 2006, American journal of clinical pathology.